PAVmed Inc. (PAVM)

PAVmed Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.78	1.54	1.19	19.64	39.74	77.26
Short-Term Investments	0.29	0.41	0.35	2.67	3.01	1.99
Cash & Short-Term Investments	4.07	1.95	1.53	22.31	42.75	79.25
Cash Growth	-7.01%	27.41%	-93.13%	-47.81%	-46.06%	352.38%
Receivables	0.02	0.02	0.02	0.06	0.02	0.2
Inventory	0.21	0.24	0.27	0.54	0.26	0.53
Prepaid Expenses	0.35	0.21	0.23	0.85	0.3	1.86
Other Current Assets	0.21	0.14	0.12	0.74	0.6	0.81
Total Current Assets	4.86	2.56	2.16	24.5	43.93	82.64
Property, Plant & Equipment	1.81	2.08	2.65	6.05	5.49	1.59
Long-Term Investments	33.49	34.12	25.64	-	-	-
Other Intangible Assets	-	-	-	1.42	3.45	2.03
Other Long-Term Assets	0.05	0.06	0.21	1.15	1.12	0.73
Total Assets	40.21	38.81	30.66	33.12	53.98	86.98

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.06	0.68	0.66	1.79	2.7	3.3
Accrued Expenses	2.46	1.72	4.81	5.75	3.7	4.23
Short-Term Debt	-	11.1	29.1	44.2	33.65	-
Current Portion of Leases	0.57	0.57	0.51	1.57	1.14	-
Other Current Liabilities	-	0.77	0.36	0.87	0.01	0.03
Total Current Liabilities	4.09	14.84	35.45	54.18	41.2	7.56
Long-Term Debt	15.1	-	-	-	-	-
Long-Term Leases	1.4	1.68	2.25	2.96	1.85	-
Total Liabilities	20.91	16.51	37.69	57.14	43.05	7.56

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.01	0	0	0.01	0.01	0.09
Additional Paid-In Capital	295.7	268.02	249.15	237.6	216.2	198.07
Retained Earnings	-264.51	-258.73	-254.97	-294.43	-228.17	-138.91
Treasury Stock	-	-	-	-	-0.41	-
Total Common Equity	31.2	9.29	-5.81	-56.82	-12.38	59.25
Minority Interest	-15.74	-11.67	-4.54	29.81	20.62	17.75
Shareholders' Equity	19.31	22.3	-7.03	-24.02	10.93	79.42
Total Liabilities & Equity	40.21	38.81	30.66	33.12	53.98	86.98

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	17.07	13.35	31.86	48.73	36.64	-
Net Cash (Debt)	-13	-11.4	-30.33	-26.41	6.11	79.25
Net Cash Growth	-	-	-	-	-92.29%	2998.01%
Net Cash Per Share	-5.48	-17.00	-13.95	-109.58	30.88	460.05
Filing Date Shares Outstanding	6.99	6.32	0.56	0.31	0.22	0.19
Total Common Shares Outstanding	6.27	0.93	0.37	0.29	0.21	0.19
Working Capital	0.77	-12.28	-33.28	-29.68	2.73	75.08
Book Value Per Share	4.98	10.01	-15.57	-198.72	-58.93	308.69
Tangible Book Value	31.2	9.29	-5.81	-58.25	-15.82	57.22
Tangible Book Value Per Share	4.98	10.01	-15.57	-203.70	-75.33	298.12
Machinery	-	1.43	1.4	3.48	3.23	1.68
Construction In Progress	-	0	0	0.02	0.03	0.04
Leasehold Improvements	-	0	0	0	0	0

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 2, 2026

Data Sources Report a data error